Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Cardiol Rep. 2011 Apr;13(2):138-44. doi: 10.1007/s11886-011-0168-3.

Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Author information

1
Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University, CA 94305-5406, USA. irogers@stanford.edu

Abstract

Conventional algorithms and noninvasive imaging tests for the identification of stable, hemodynamically significant coronary artery disease offer little insight into the detection of potentially vulnerable and inflamed coronary plaques, those most likely to rupture and cause acute coronary syndromes. Positron emission tomography (PET) with fluorodeoxyglucose (FDG) serves as a potential novel modality for the identification of plaque inflammation, as initial studies in animal and human studies have demonstrated that FDG uptake correlates with macrophage accumulation and inflammation. Therapy with anti-inflammatory agents has also been demonstrated in the arterial vasculature to reduce plaque FDG uptake. Although imaging of coronary inflammation with FDG-PET holds tremendous promise, several hurdles remain to be surmounted prior to widespread clinical application.

PMID:
21274660
DOI:
10.1007/s11886-011-0168-3
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center